Liquidia Corporation Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.33 | $157.41 M | -2.5 | 51 | $0 |
 AGEN
|
Agenus Inc. | $3.33 | $348.59 M | 1.43 | 389 | $156.31 M |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.37 | $120.37 M | -1.65 | 384 | $380.79 M |
 BMRN
|
BioMarin Pharmaceutical Inc. | $64.30 | $15.32 B | 76.12 | 3401 | $2.42 B |
 GERN
|
Geron Corporation | $4.10 | $2.72 B | -13.5 | 141 | $237,000 |
 GOSS
|
Gossamer Bio, Inc. | $0.70 | $124.06 M | -0.65 | 135 | $0 |
 IMCR
|
Immunocore Holdings plc | $32.90 | $2.08 B | -26.72 | 497 | $249.43 M |
 INZY
|
Inozyme Pharma, Inc. | $2.71 | $286.39 M | -3.43 | 59 | $0 |
 KALV
|
KalVista Pharmaceuticals, Inc. | $9.96 | $492.76 M | -3.74 | 150 | $0 |
 KRON
|
Kronos Bio, Inc. | $0.90 | $44.62 M | -0.37 | 58 | $6.29 M |
 LEGN
|
Legend Biotech Corporation | $40.50 | $8.31 B | -17.66 | 2400 | $285.14 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.30 | $611.84 M | -9.99 | 42 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.19 | $19.53 M | -0.27 | 88 | $1.56 M |
 MIRM
|
Mirum Pharmaceuticals, Inc. | $44.63 | $1.18 B | -6.7 | 311 | $186.37 M |
 NRXP
|
NRx Pharmaceuticals, Inc. | $1.26 | $34.35 M | 0.62 | 2 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $4.79 | $116.38 M | -4.5 | 13 | $0 |
 PCVX
|
Vaxcyte, Inc. | $90.78 | $7.72 B | -16.54 | 254 | $0 |
 REPL
|
Replimune Group, Inc. | $16.00 | $485.18 M | -2.44 | 331 | $0 |
 TECH
|
Bio-Techne Corporation | $71.45 | $12.23 B | 62.1 | 3100 | $1.16 B |
 TERN
|
Terns Pharmaceuticals, Inc. | $5.75 | $462.44 M | -5.67 | 66 | $0 |
 UTHR
|
United Therapeutics Corporation | $371.79 | $12.20 B | 13.02 | 1168 | $2.33 B |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.34 | $169.62 M | -1.51 | 127 | $0 |